Which federal agency does The Endocrine Society comment on most?

The Endocrine Society is most active at the Environmental Protection Agency.

The Endocrine Society

Unclaimed

Website

www.endocrine.org

Engagement overview

The Endocrine Society has filed 60 public comments across 56 dockets at 8 federal agencies, most actively at the Environmental Protection Agency.

Comments filed

Dockets engaged

Agencies

Feb 20, 2026

Last filing

Is this your organization?

Claim The Endocrine Society to unlock owner-only intelligence across your 56 dockets:

Coalition map — every organization that files alongside you
Ally & opposition tags on your co-filers
AI briefs on the rulemakings you engage
Deadline calendar & alerts for open comment windows

Claim this profile →or book a meetingFree · verify instantly with your work email.

Agency footprint

All agencies EPA34 FDA10 CMS4 HHS3 SSA2 FTC1 USTR1 OMB1

Dockets (56)

sorted by most recent filing

FDANonrulemakingFDA-2025-N-6743

Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information

1 of your filingslast filed Feb 20, 202611 co-filers

EPARulemakingEPA-HQ-OPPT-2025-0260

Procedures for Chemical Risk Evaluation Under the Toxic Substances Control Act (TSCA)

1 of your filingslast filed Nov 13, 202570 co-filers

FDANonrulemakingFDA-2025-N-1733

Tool for the Prioritization of Food Chemicals for Post-Market Assessment

1 of your filingslast filed Jul 22, 202532 co-filers

FDANonrulemakingFDA-2024-N-3609

Development of an Enhanced Systematic Process for FDA’s Post-Market Assessment of Chemicals in Food; Public Meeting; Request for Comments

2 of your filingslast filed Mar 11, 202532 co-filers

EPANonrulemakingEPA-HQ-OPP-2009-0059

Per- and polyfluoroalkyl substances (PFAS): Perfluorooctanoic acid (PFOA) and Perfluorooctanesulfonic acid (PFOS) National Primary Drinking Water Regulation Rulemaking

1 of your filingslast filed May 31, 2023119 co-filers

FTCRulemakingFTC-2023-0007

Non-Compete Clause Rule

1 of your filingslast filed Apr 21, 2023300 co-filers

EPANonrulemakingEPA-HQ-OPP-2021-0756

Endocrine Disruptor Screening Program New Approach Methods

1 of your filingslast filed Mar 23, 20238 co-filers

HHSRulemakingHHS-OS-2022-0012

Nondiscrimination in Health Programs and Activities

1 of your filingslast filed Oct 24, 2022181 co-filers

EPARulemakingEPA-HQ-OLEM-2019-0341

Designation of Perfluoroctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS) as CERCLA Hazardous Substances

1 of your filingslast filed Sep 30, 2022109 co-filers

EPANonrulemakingEPA-HQ-OA-2021-0403

Draft FY 2022-2026 EPA Strategic Plan

1 of your filingslast filed Nov 17, 202134 co-filers

OMBNonrulemakingOMB-2021-0005

Methods and Learning Practices for Advancing Equity in Support for Underserved Communities Through Government

1 of your filingslast filed Jul 2, 2021141 co-filers

EPANonrulemakingEPA-HQ-OPP-2008-0850

Registration Review of Chlorpyrifos (PC Code 059101)

1 of your filingslast filed Mar 12, 202166 co-filers

EPANonrulemakingEPA-HQ-OPPT-2019-0502

Toxic Substances Control Act (TSCA) Science Advisory Committee on Chemicals (SACC) - Review of Risk Evaluation for Perchloroethylene

1 of your filingslast filed Jul 9, 202014 co-filers

EPANonrulemakingEPA-HQ-OPPT-2018-0504

Dicyclohexyl phthalate; TSCA Review

1 of your filingslast filed Jun 11, 202016 co-filers

EPANonrulemakingEPA-HQ-OPP-2008-0844

Imidacloprid Registration Review

1 of your filingslast filed May 6, 2020132 co-filers

EPANonrulemakingEPA-HQ-OPP-2012-0329

Acetamiprid Registration Review

1 of your filingslast filed May 5, 202033 co-filers

EPANonrulemakingEPA-HQ-OPP-2011-0920

Dinotefuran Registration Review

1 of your filingslast filed May 5, 202061 co-filers

EPANonrulemakingEPA-HQ-OPP-2011-0865

Clothianidin Registration Review

1 of your filingslast filed May 5, 2020109 co-filers

EPARulemakingEPA-HQ-OA-2018-0259

Strengthening Transparency in Regulatory Science

2 of your filingslast filed Apr 9, 2020230 co-filers

EPANonrulemakingEPA-HQ-OPPT-2018-0433

Di-ethylhexyl phthalate (DEHP)(1,2-Benzene- dicarboxylic acid, 1,2- bis(2-ethylhexyl) ester; TSCA Review

1 of your filingslast filed Jul 10, 201916 co-filers

EPANonrulemakingEPA-HQ-OPPT-2018-0462

4,4'-(1-Methylethylidene)bis[2, 6-dibromophenol] (TBBPA); TSCA Review

1 of your filingslast filed Jul 10, 201914 co-filers

EPANonrulemakingEPA-HQ-OPPT-2018-0503

Dibutyl phthalate (DBP) (1,2-Benzene- dicarboxylic acid, 1,2- dibutyl ester); TSCA Review

1 of your filingslast filed Jul 3, 201911 co-filers

EPANonrulemakingEPA-HQ-OPPT-2018-0501

Butyl benzyl phthalate (BBP) 1,2-Benzene- dicarboxylic acid, 1- butyl 2(phenylmethyl) ester; TSCA Review

1 of your filingslast filed Jul 3, 201912 co-filers

FDANonrulemakingFDA-2019-N-1132

The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products; Date for Public Hearing; Request for Comments

1 of your filingslast filed May 10, 20195 co-filers

EPANonrulemakingEPA-HQ-OPPT-2018-0210

Problem Formulations for the Risk Evaluations to be Conducted for the First Ten Chemical Substances under the Toxic Substances Control Act, and Application of Systematic Review in TSCA Risk Evaluations; Notice of Availability

1 of your filingslast filed Sep 13, 201831 co-filers

USTRNonrulemakingUSTR-2018-0005

Notice of Determination and Request for Public Comment Concerning Proposed Determination of Action Pursuant to Section 301

1 of your filingslast filed May 10, 2018263 co-filers

EPANonrulemakingEPA-HQ-OPPT-2017-0559

TSCA Alternative Testing Methods Strategy

1 of your filingslast filed Apr 30, 201816 co-filers

EPANonrulemakingEPA-HQ-OPPT-2017-0586

Approaches for Identifying Potential Candidates for Prioritization for Risk Evaluation Under Amended TSCA; Notice of Public Meeting and Opportunity for Public Comment

1 of your filingslast filed Jan 25, 201826 co-filers

EPANonrulemakingEPA-HQ-OPPT-2017-0585

New Chemicals Review Program under the Amended Toxic Substances Control Act

1 of your filingslast filed Jan 24, 201820 co-filers

EPANonrulemakingEPA-HQ-OPP-2017-0214

FIFRA Scientific Advisory Panel; Notice of Public Meeting: Continuing Development of Alternative High-Throughput Screens to Determine Endocrine Disruption, Focusing on Androgen Receptor, Steroidogenesis, and Thyroid Pathways

1 of your filingslast filed Aug 22, 20173 co-filers

EPANonrulemakingEPA-HQ-OPP-2013-0251

Simazine Registration Review

1 of your filingslast filed Mar 3, 201719 co-filers

EPANonrulemakingEPA-HQ-OPP-2013-0250

Propazine Registration Review

1 of your filingslast filed Mar 3, 201712 co-filers

EPANonrulemakingEPA-HQ-OPP-2013-0266

Atrazine Registration Review

1 of your filingslast filed Mar 3, 2017138 co-filers

EPANonrulemakingEPA-HQ-OPPT-2016-0474

Toxic Substances Control Act (TSCA), Science Advisory Committee on Chemicals (SACC) - Establishment of a Federal Advisory Committee and Request for Nominations

1 of your filingslast filed Oct 14, 201619 co-filers

EPARulemakingEPA-HQ-OPPT-2016-0399

Risk-Based Prioritization Procedural Rule under TSCA section 6(b)(1)

1 of your filingslast filed Aug 25, 201620 co-filers

FDANonrulemakingFDA-2016-F-1253

Filing of Food Additive Petition: Breast Cancer Fund, Center for Environmental Health, Center for Food Safety, Center for Science In The Public Interest, Clean Water Action, Consumer Federation of America, Earthjustice, Environmental Defense Fund, Improving Kids' Environment, Learning Disabilities Association of America, and Natural Resources Defense Council; Filing of Food Additive Petition

1 of your filingslast filed Jul 26, 201610 co-filers

FDARulemakingFDA-2012-N-1210

Food Labeling: Revision of the Nutrition and Supplement Facts Labels

1 of your filingslast filed Sep 28, 2015111 co-filers

FDANonrulemakingFDA-2014-N-1497

Toxicological Principles for the Safety Assessment of Food Ingredients; Public Meeting on Updates and Safety and Risk Assessment Considerations

1 of your filingslast filed Apr 22, 201519 co-filers

SSARulemakingSSA-2011-0081

Revised Listings for Growth Disorders and Weight Loss in Children

1 of your filingslast filed Jul 23, 20132 co-filers

EPANonrulemakingEPA-HQ-OAR-2007-0268

Updates to Protective Action Guides Manual: Protective Action Guides (PAGs) and Planning Guidance for Radiological Incidents

1 of your filingslast filed Jul 16, 201318 co-filers

FDANonrulemakingFDA-2012-N-1154

Framework for Pharmacy Compounding: State and Federal Roles

1 of your filingslast filed Jan 23, 201319 co-filers

CMSRulemakingCMS-2012-0083

Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013 (CMS-1590-P)

2 of your filingslast filed Sep 4, 2012516 co-filers

FDANonrulemakingFDA-2012-N-0171

Using Innovative Technologies and Other Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription

1 of your filingslast filed Mar 27, 201221 co-filers

CMSRulemakingCMS-2011-0191

Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests (CMS-5060-P)

1 of your filingslast filed Feb 26, 2012106 co-filers

CMSRulemakingCMS-2010-0259

Medicare Program; Accountable Care Organizations and the Medicare Shared Saving Program

1 of your filingslast filed Jun 17, 2011385 co-filers

EPANonrulemakingEPA-HQ-OPPT-2010-0877

Endocrine Disruptor Screening Program (EDSP), Weight of Evidence: Evaluating Results of EDSP Tier 1 Screening to Identify the Need for Tier 2 Testing

1 of your filingslast filed Jan 6, 20115 co-filers

CMSRulemakingCMS-2010-0205

Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011

1 of your filingslast filed Sep 24, 2010189 co-filers

SSARulemakingSSA-2006-0114

Medical Criteria for Evaluating Endocrine Disorders

1 of your filingslast filed Feb 12, 20102 co-filers

FDANonrulemakingFDA-2009-N-0674

Participation of Certain Population Subsets in Clinical Drug Trials; Request for Comment

1 of your filingslast filed Mar 6, 200910 co-filers

Attribution is name-based and imperfect. Firmographic data is third-party sourced and shown for demonstration. regulations.gov data is public record.